XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue recognition and accounts receivable (Tables)
6 Months Ended
Jun. 30, 2024
Revenue Recognition And Accounts Receivable [Abstract]  
Schedule of Net Sales by Product Category by Reporting Segment

The table below presents net sales by product category by reporting segment:

 

 

 

Three Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

 

Change

 

Bone Growth Therapies

 

$

59,135

 

 

$

52,662

 

 

 

12.3

%

Spinal Implants, Biologics, and Enabling Technologies

 

 

108,899

 

 

 

105,314

 

 

 

3.4

%

Global Spine

 

 

168,034

 

 

 

157,976

 

 

 

6.4

%

Global Orthopedics

 

 

30,586

 

 

 

29,040

 

 

 

5.3

%

Net sales

 

$

198,620

 

 

$

187,016

 

 

 

6.2

%

 

 

 

Six Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

 

Change

 

Bone Growth Therapies

 

$

111,612

 

 

$

100,376

 

 

 

11.2

%

Spinal Implants, Biologics, and Enabling Technologies

 

 

217,715

 

 

 

206,806

 

 

 

5.3

%

Global Spine

 

 

329,327

 

 

 

307,182

 

 

 

7.2

%

Global Orthopedics

 

 

57,901

 

 

 

55,038

 

 

 

5.2

%

Net sales

 

$

387,228

 

 

$

362,220

 

 

 

6.9

%

Schedule of Components Net Sales

The table below presents product sales and marketing service fees, which are both components of net sales:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Product sales

 

$

185,417

 

 

$

174,078

 

 

$

361,248

 

 

$

336,326

 

Marketing service fees

 

 

13,203

 

 

 

12,938

 

 

 

25,980

 

 

 

25,894

 

Net sales

 

$

198,620

 

 

$

187,016

 

 

$

387,228

 

 

$

362,220

 

Allowances for Expected Credit Losses

The following table provides a detail of changes in the Company’s allowance for expected credit losses for the three and six months ended June 30, 2024 and 2023:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Allowance for expected credit losses beginning balance

 

$

8,398

 

 

$

6,691

 

 

$

7,130

 

 

$

6,419

 

Addition resulting from the Merger with SeaSpine

 

 

 

 

 

 

 

 

 

 

 

137

 

Current period provision for expected credit losses

 

 

197

 

 

 

282

 

 

 

1,573

 

 

 

490

 

Write-offs charged against the allowance and other

 

 

(184

)

 

 

6

 

 

 

(203

)

 

 

(120

)

Effect of changes in foreign exchange rates

 

 

(43

)

 

 

36

 

 

 

(132

)

 

 

89

 

Allowance for expected credit losses ending balance

 

$

8,368

 

 

$

7,015

 

 

$

8,368

 

 

$

7,015